Searchable abstracts of presentations at key conferences in endocrinology

ea0095p14 | Bone | BSPED2023

Clinical utility of individual biochemical markers in screening for metabolic bone disease of prematurity

Elmeligy Eman , Chinoy Amish

Introduction: Metabolic bone disease of prematurity (MBDP) is a common condition in preterm and low birth weight infants, characterised by under-mineralisation of bone due to inadequate mineral supply, which can increase the risk of fractures. Screening is undertaken using biochemical markers, typically serum phosphate (PO4), alkaline phosphatase (ALP) and parathyroid hormone (PTH), although the objective clinical utility of these markers individually has not ...